what is ghk-cu.
GHK-Cu (also written GHKCu, GHK Cu, or GHK-copper) is a naturally occurring copper-binding tripeptide consisting of the amino acids glycine, histidine, and lysine bound to a copper ion. The peptide is present in human plasma, saliva, and urine, with circulating concentrations declining progressively with age.
GHK-Cu is not a ballpoint pen, writing implement, or office supply. It is a research peptide compound. The term GHK-Cu peptide pen refers to a pre-filled peptide delivery device used in laboratory research settings, not a writing instrument.
The full chemical name is copper tripeptide-1, with the INCI synonym copper peptide GHK. The free tripeptide has the molecular formula C14H24N6O4 and a molar mass of approximately 340.4 g/mol. The copper-bound complex (C14H22CuN6O4, approximately 402 g/mol) is the form used in most published research, distinguished from the apo-peptide by its characteristic blue solution colour.
GHK was first identified in human serum by Loren Pickart in 1973 (Pickart and Thaler, Nature New Biology, 1973), where it was shown to influence liver cell viability and growth. Its copper-binding properties and origin from albumin breakdown were characterised in subsequent work, and the copper-bound complex remains the most widely cited copper-binding peptide in the peer-reviewed literature.
How GHK-Cu differs from GHK
GHK is the free tripeptide. GHK-Cu is the tripeptide complexed with a copper(II) ion. The two have distinct biological activity profiles: the apo-peptide is comparatively inert, while the copper complex is the species that most peer-reviewed studies describe as biologically active. Where literature refers simply to "GHK," check the methods section for whether the copper-bound form was used.
Why GHK-Cu is written as GHK-Cu, GHKCu, or GHK copper
Four variant spellings appear across the literature and commercial sources. Each refers to the same compound, and the differences are typographic, not chemical.
The hyphenated form preferred by the peer-reviewed biochemistry literature, including Pickart's original papers. Reads as "glycyl-histidyl-lysyl copper" and is the spelling used on Certificates of Analysis from established analytical labs.
A compact form common in product listings and consumer-facing copy. Identical compound, identical chemistry. Often seen alongside "GHKCu pen" in commercial contexts where the hyphen has been dropped for URL or branding reasons.
The space-separated form used by writers who treat "Cu" as a separate elemental symbol. Mechanically the same compound. Search engines occasionally treat this variant as a distinct query, which is why suppliers sometimes index against it explicitly.
Long-form descriptors. "Copper tripeptide-1" is the INCI name used in cosmetic and dermatology literature. "GHK copper" is the everyday spoken form. Both resolve to the same compound described in this guide.
mechanism of action.
The biological activity of GHK-Cu is thought to be driven by two related properties: high-affinity copper chelation, and direct interaction with cellular signalling pathways. The two are difficult to disentangle experimentally because copper itself acts as a cofactor for enzymes in pathways the peptide also touches directly.
Four mechanistic threads dominate the published literature.
GHK binds Cu(II) with high affinity (logK around 16.4) and shuttles the bound copper across cellular membranes. In vitro studies have used this transport activity to deliver copper to fibroblast and keratinocyte cultures where copper-dependent enzymes can act on it.
A review by Pickart and Margolina (Int J Mol Sci, 2018;19(7):1987) summarises bioinformatic analyses reporting that GHK and the copper complex modulate expression of several thousand human genes across pathways relevant to wound repair, DNA repair, and antioxidant defence.
Published in vitro studies have documented effects on fibroblast collagen synthesis, glycosaminoglycan production, and matrix metalloproteinase activity. Researchers use GHK-Cu as a tool for probing extracellular matrix biology in three-dimensional culture models.
In vitro studies have observed copper-dependent superoxide dismutase activity in GHK-Cu-treated cell cultures. The copper binding geometry is thought to mimic the active site of native SOD enzymes, providing a useful research tool for oxidative stress models.
Effects observed in fibroblast research models
In vitro studies have documented GHK-Cu effects on dermal fibroblast collagen synthesis, glycosaminoglycan production, and matrix remodelling. The foundational study by Maquart and colleagues (FEBS Letters, 1988;238(2):343-346) reported stimulation of collagen synthesis in fibroblast cultures by GHK-Cu at nanomolar concentrations.
Effects observed in skin and dermatological research
Research has examined GHK-Cu's effects on extracellular matrix biology in skin tissue. Siméon and colleagues (J Invest Dermatol, 2000;115(6):962-968) reported modulation of glycosaminoglycan expression and small proteoglycan content in wound tissue exposed to the GHK-Cu tripeptide-copper complex, providing a research tool for studying matrix remodelling pathways.
Hair follicle research
In vitro work has examined GHK-Cu's potential effects on hair follicle biology, with some published findings reporting altered gene expression profiles in dermal papilla cell cultures exposed to the copper complex. This research area remains preclinical and is less extensively documented than dermal fibroblast studies.
Antioxidant properties in vitro
Studies have observed copper-dependent antioxidant activity in cell-free and cell culture systems, consistent with the copper binding geometry of GHK-Cu mimicking the active site of native superoxide dismutase. Researchers use this property as a research tool when probing oxidative stress pathways.
All effects described in this section have been observed in laboratory research models. None constitute therapeutic claims or clinical findings.
References
The four primary peer-reviewed sources referenced in this guide. Researchers should consult the originals for full methods and context.
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-87. PMID: 4349963.
- Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346.
- Siméon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: Modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. J Invest Dermatol. 2000;115(6):962-968.
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520. doi:10.3390/ijms19071987.
research applications.
GHK-Cu appears across five principal research application areas in the published literature. Each represents an active line of investigation in laboratory and preclinical research, none of which has translated into approved clinical interventions.
Skin and dermatological research
The most heavily published application area. Investigators study GHK-Cu's effects on dermal fibroblast biology, matrix remodelling enzymes, and epithelial cell behaviour in skin culture models. The compound serves as a research benchmark in extracellular matrix studies.
Wound healing research
Animal model studies have examined GHK-Cu's interaction with the inflammatory and proliferative phases of wound repair. Investigators have reported effects on cytokine expression and granulation tissue formation in rodent and porcine models. Findings remain preclinical.
Hair follicle research
In vitro studies have observed GHK-Cu effects on cultured dermal papilla cells and follicular gene expression panels. Active research area, not a clinical intervention.
Anti-inflammatory research
Cell culture studies have reported modulation of TNF-alpha, IL-6, and IL-1 beta expression in GHK-Cu-treated macrophage and fibroblast cultures. The compound is used as a research tool for probing inflammatory signalling pathways.
Antioxidant and oxidative stress research
The copper binding chemistry of GHK-Cu intersects with research on copper-dependent antioxidant enzymes including superoxide dismutase and ceruloplasmin. Investigators have used the compound in cell culture studies probing oxidative stress response pathways.
the peptide pen format.
A research peptide pen is a pre-filled delivery device pre-loaded with reconstituted peptide at a fixed concentration. The format originated in clinical injection devices and has been adapted for research handler use where dose consistency across experiments matters more than per-experiment flexibility.
The pen format differs from the lyophilised vial format in three practical ways. Pens arrive ready to use with no reconstitution step. The seal limits airborne contamination during repeated draws. The graduated dose mechanism provides volume consistency that is difficult to match with a manual draw from a stoppered vial.
The trade-off is rigidity. A pen format locks in the concentration set at manufacture, so researchers who need to vary working dilutions across a study still need to dilute the drawn aliquot into their experimental buffer. For a single-concentration study or a series of replicates at the same dose, the format reduces handler variance considerably.
Storage and handling follow standard reconstituted peptide protocol: refrigerated storage at 2 to 8 degrees Celsius after first use, with the stability window documented on the Certificate of Analysis. Cold-chain integrity from supplier through delivery is a precondition for any subsequent stability claim.
The BodyPharm UAE GHK-Cu peptide pen is supplied at a fixed concentration with batch-specific HPLC purity and copper complex stoichiometry on the CoA.
quality and coa standards.
Research-grade GHK-Cu is defined by the documentation that accompanies it. A peptide with a published synthesis route but no batch-specific Certificate of Analysis is not a research material; it is an unknown. Researchers procuring GHK-Cu in the UAE or anywhere else should expect the following at minimum.
- HPLC purity greater than 98 percent, ideally above 99 percent for sensitive research applications.
- Mass spectrometry confirmation of the GHK peptide sequence and the copper complex stoichiometry.
- Batch-specific Certificate of Analysis from an independent third-party lab, not just an in-house result.
- Endotoxin testing where the material is intended for cell culture or animal research.
- Documented cold-chain handling from synthesis through shipping, with temperature logs available on request.
For BodyPharm UAE GHK-Cu, the per-batch lab report is published at /uae/lab-results/ghk-cu-50. The CoA documents HPLC purity, mass spectrometry confirmation, and the in-house concentration assay. Independent third-party reports are available on request.
If there is no CoA, there is no peptide. Only powder.
uae sourcing and regulatory context.
Research peptides are not pharmaceuticals under UAE Federal Decree-Law No. 38 of 2024 and are not regulated as medicines. GHK-Cu in the research peptide format is supplied for laboratory research use only, not for human or veterinary therapeutic use. Researchers are responsible for ensuring their handling and use comply with their institution's research governance and any applicable local research-ethics requirements.
The UAE has emerged as a regional hub for research peptide supply, partly because of the climate-driven cold-chain expertise developed across the GCC pharmaceutical distribution network. Suppliers operating from Dubai, Abu Dhabi, and Sharjah can typically meet same-day delivery to Dubai locations and one to three day delivery to other emirates.
Cold-chain shipping in the GCC requires considered packaging. Ambient temperatures across the summer months routinely exceed 40 degrees Celsius, well above the stability window for reconstituted peptide solutions. See the dedicated reference at peptide delivery and GCC cold chain for the operational considerations.
For the full UAE regulatory context covering research peptide procurement, including the relevant law citations and the distinction between research and therapeutic use, see Is it legal to buy peptides in Dubai and the UAE.
frequently asked questions.
The questions below cover the most common queries from UAE-based researchers and procurement teams. Each answer is independently sourced and can be cross-referenced against the linked product pages and lab results.
What does GHK-Cu stand for?
GHK-Cu stands for glycyl-L-histidyl-L-lysine copper complex. "GHK" is the single-letter amino acid code for the tripeptide glycine-histidine-lysine, and "Cu" is the chemical symbol for copper. The compound is also referenced as copper tripeptide-1, copper peptide GHK, or simply GHK copper. All four terms describe the same molecule.
Is GHK-Cu the same as GHKCu or GHK Cu peptide?
Yes. GHK-Cu, GHKCu, and GHK Cu are three spellings of the same compound. The hyphenated form appears in peer-reviewed literature, the unspaced form is common in product listings, and the space-separated form is used by writers who treat Cu as a separate elemental symbol. Chemistry, source, and research applications are identical.
How is GHK-Cu different from copper peptides in general?
GHK-Cu is one specific copper-binding tripeptide. "Copper peptides" is a broader umbrella covering any peptide sequence that binds copper, including short oligopeptides used in cosmetic chemistry. GHK-Cu is the most extensively studied member of that family and serves as the literature benchmark against which newer copper peptides are characterised.
What is a GHK-Cu peptide pen?
A GHK-Cu peptide pen is a research delivery device pre-loaded with reconstituted GHK-Cu solution at a fixed concentration. It is not a writing implement. The format provides dosing consistency, sterility through the device seal, and removes the need for laboratory reconstitution at the point of use. Research handlers use the pen format when consistent dose volumes across experiments are a design requirement.
Where can I buy GHK-Cu in Dubai or the UAE?
BodyPharm UAE supplies GHK-Cu in the pre-filled peptide pen format with HPLC-verified purity and independent third-party Certificates of Analysis. Same-day delivery is available across Dubai, with one to three day delivery to other emirates. The product page at /uae/product/ghk-cu-pen carries the current batch information.
Is GHK-Cu legal in the UAE for research purposes?
Research peptides like GHK-Cu are not classified as pharmaceuticals under UAE Federal Decree-Law No. 38 of 2024 and are supplied for laboratory research use only, not for human or veterinary therapeutic use. See the full regulatory context in the BodyPharm legal overview at /uae/blog/is-it-legal-to-buy-peptides-dubai-uae-regulations.
What concentration of GHK-Cu is used in research?
Published in vitro studies typically use GHK-Cu concentrations in the nanomolar to low micromolar range for cell culture work, with concentrations selected based on the specific assay and target pathway. Pre-filled research pens are typically supplied at a fixed mg/mL concentration documented on the Certificate of Analysis. Researchers should select working dilutions appropriate to their published protocol.
How is GHK-Cu stored?
Lyophilised GHK-Cu is moderately stable at room temperature for short periods but is best stored at minus 20 degrees Celsius in amber or opaque vials away from light and moisture. Reconstituted GHK-Cu in solution should be stored at 2 to 8 degrees Celsius and used within the stability window documented by the supplier. The characteristic blue colouration of the solution is normal and reflects the copper complex absorbance.
related research peptides.
GHK-Cu sits within a broader research peptide category that BodyPharm UAE supplies and documents in parallel. The references below provide background on adjacent research compounds frequently studied alongside GHK-Cu.
Two of the most studied tissue-repair research peptides, often investigated in parallel with GHK-Cu in matrix remodelling models. A side-by-side reference covering pathway differences and research applications. Read more.
A coenzyme central to mitochondrial energy metabolism and DNA repair. Researchers studying age-related cellular biology often examine NAD+ alongside GHK-Cu given the overlap in gene expression pathways. Read more.
A mitochondria-derived peptide active in AMPK pathway research. Used in metabolic homeostasis studies that frequently intersect with the antioxidant pathways relevant to GHK-Cu research. Read more.
For the full BodyPharm UAE research peptide catalogue with current batch CoAs, see /uae/peptides.
HPLC-verified GHK-Cu in the pre-filled research pen format. Batch-specific CoA, same-day Dubai delivery.